Filter
2398
Filtered Results: 2398
Text search:
Global
Vaccine
Action
Plan
Featured
Recommendations
244
New Publications
633
Language
Document type
No document type
1122
Studies & Reports
490
Guidelines
314
Strategic & Response Plan
199
Manuals
145
Fact sheets
48
Training Material
35
Situation Updates
30
Brochures
4
Resource Platforms
4
Infographics
4
Online Courses
2
App
1
Countries / Regions
Global
143
Kenya
68
Nigeria
64
India
62
Liberia
54
Africa
51
Sierra Leone
49
Ethiopia
47
South Africa
43
Congo, Democratic Republic of
40
Latin America and the Carribbean
39
Western and Central Europe
37
Uganda
35
Nepal
33
Ghana
31
Tanzania
31
Malawi
30
Zambia
28
Senegal
26
Bangladesh
26
Guinea
23
Syria
21
Myanmar / Burma
21
Rwanda
20
South–East Asia Region
20
Ukraine
19
East and Southern Africa
19
Zimbabwe
18
Cameroon
17
Haiti
17
Pakistan
17
West and Central Africa
16
Eastern Europe
16
Philippines
14
South Sudan
14
Namibia
14
Lesotho
14
Asia
14
Burkina Faso
13
Indonesia
13
Central African Republic
13
Brazil
13
Mozambique
12
Yemen
12
Venezuela
12
Middle East and North Africa
11
Afghanistan
9
Cambodia
9
Western Pacific Region
9
Eastern Europe and Central Asia
9
Sudan
8
Botswana
8
Madagascar
8
Mali
7
Somalia
7
Benin
7
Germany
6
Colombia
6
Russia
5
Niger
4
Iraq
4
Jordan
4
Lebanon
4
Turkey
4
Thailand
4
Laos
4
Guinea-Bissau
3
Côte d’Ivoire / Ivory Coast
3
Togo
3
Chad
3
Argentina
3
Peru
3
Eswatini/ Swaziland
3
Burundi
3
Bolivia
3
Mexico
3
Chile
3
Paraguay
3
Moldova
3
Vietnam
3
France
3
Spain
3
USA
2
China
2
Malaysia
2
Honduras
2
Ecuador
2
Angola
2
Sri Lanka
2
Albania
2
Southern Africa
2
Timor Leste/ East Timor
2
Iran
2
Georgia
2
North America
2
Japan
2
Morocco
1
Saudi Arabia
1
Egypt
1
Gambia
1
Papua New Guinea
1
North Macedonia
1
El Salvador
1
Guatemala
1
Nicaragua
1
Fiji
1
Palestine
1
Congo-Brazzaville
1
Tajikistan
1
Bulgaria
1
Kyrgyzstan
1
Uruguay
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
868
Clinical Guidelines
197
Public Health
158
Women & Child Health
135
Key Resources
108
Capacity Building
26
Pharmacy & Technologies
26
Annual Report MEDBOX
2
Toolboxes
COVID-19
314
AMR
161
HIV
138
Rapid Response
133
TB
123
Ebola
84
Global Health Education
79
Planetary Health
78
Conflict
62
Pharmacy
54
Health Financing Toolbox
54
NTDs
51
Caregiver
50
Polio
45
Refugee
39
Cholera
32
Mental Health
31
Natural Hazards
26
NCDs
20
Zika
19
Disability
18
Specific Hazards
8
Health Financing
2
South Sudan
1
Benchmarking is a strategic process often used by businesses and institutes to standardize performance in relation to the best practices of their sector. The World Health Organization (WHO) and partners have developed a tool with a list of benchmarks and corresponding suggested actions that can be a...
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action ...s, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidence map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans.
METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review.
CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published.
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to m...
Le Cadre d’action régional vise à aider les États Membres, l’OMS et tous les autres donateurs et partenaires à travailler ensemble pour remédier systématiquement et progressivement aux diverses faiblesses relevées dans les principaux doma...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati...
Pre-Publication draft version. Lat reviewed on 7th July 2017
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further prog...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progr...
Ebola Virus Disease Outbreak Response Plan in West Africa July to December 2014. Annex 1
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and p...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to...
India is experiencing rapid demographic and epidemiological transitions with NCDs causing significant disability, morbidity and mortality both in urban and rural populations and across all socioeconomic strata. According to the ICMR State Level Disease Burden Initiative, in 2016, NCDs accounted to a...
